PerkinElmer – Developing Products in China for China Harvard Case Solution & Analysis

Sym-Bio, entrepreneurial Chinese diagnostic company with a production line of infectious disease testing, has agreed to be acquired by PerkinElmer, international corporations with businesses newborn testing services in the life sciences and the environment. Sym-Bio wants to accelerate its growth and competitiveness in China through this strategic move, and PerkinElmer is seeking to expand its access to the Chinese market, using price advantages, working in China, and then the talent pool of young Chinese scientists. Strategic and operational integration of Sym-Bio in PerkinElmer studied through the prism of the founder and CEO of Sym-Bio and the acquiring company.
To enhance their effectiveness, color cases should be printed in color. "Hide
by Vicki L. Sato, Christoph Jaeker, Karim Reda Source: HBS 17 pages. Publication Date: November 13, 2011. Prod. #: 612032-PDF-ENG

PerkinElmer – Developing Products in China for China Case Solution Other Similar Case Solutions like

PerkinElmer – Developing Products in China for China

Share This